We wish to investigate whether blocking IL-10 at the time of immunisation, which increases the numbers of antigen specific IFNγ CD8+ T cells, better prevent TC-1 tumour growth in mice than immunisation without IL-10 signalling blockage, especially in therapeutic setting. The gene discussed is IL10; the disease is neoplasm.